Skip to content

RECOVERY ROOM EARLY WARNING SCORE

A NEW EARLY WARNING SCORE TO SUPPORT CLINICAL DECISION PROCESSES IN POSTANESTHETIC FOLLOW-UP: RECO-EWS

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07051421
Enrollment
208
Registered
2025-07-04
Start date
2025-07-01
Completion date
2025-12-01
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Warning Score

Brief summary

In this study, we aimed to develop a scoring system that facilitates patient risk stratification in the recovery room during the postanesthetic follow-up period and can objectively identify patients in need of early intervention.

Interventions

In the RECO-EWS scoring system we designed; 0-7 low risk, 7-10 medium risk, ≥10 high risk, postoperative stay findings of high-risk patients and, if necessary, new cut-off values are determined for each parameter in the scoring system according to the analysis results.

Sponsors

Istinye University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Those over 18 years of age, * Those in ASA I-III class, * Those who have undergone planned elective surgery under general anesthesia, * Those who have been informed about the study in advance and given their consent.

Exclusion criteria

* Those under 18 years of age, * Those who underwent emergency intervention, * Those in the ASA-Ⅳ class, * Those who underwent regional anesthesia, * Those with a history of cognitive retardation, visual-hearing impairment or psychiatric disease that prevents communication, those who have previously been diagnosed with neurocognitive disorders, * Patients who could not complete the procedure, patients with data loss, * Patients whose general anesthesia duration is less than 90 minutes will not be included in the study.

Design outcomes

Primary

MeasureTime frameDescription
RECO-EWS24 HOURS0-7 low risk, 7-10 medium risk, ≥10 high risk

Contacts

Primary ContactILKE DOLGUN
ilkeser2004@gmail.com+905555485632

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026